Let us have a moment of SILENCE: Athena’s Revitalash and Jan Marini’s Masses of Lashes launched several years ago, only to be taken off the market and reformulated because of FDA regulatory issues and allegations of patent infringement over the active ingredient bimatoprost (sold as Lumigan by pharmaceutical company Allergan).
And now for a moment of SCIENCE: Lumigan is a drug that was developed to treat glaucoma. A most interesting side-effect is that its ingredient, bimatoprost, gave users longer, thicker, darker lashes in a matter of days.
Now Allergan is on the brink of FDA approval to market its own Lumigan-based eyelash growth stimulator, but it will be by prescription only.
According to an Allergan news release, the product is expected to launch in 2009 and will be marketed under the brand name Lattise.
In The Makeup Says: Our first reaction was despair. Doctors appointments, check-ups, co-pays, insurance companies? Our visions of Bambi-like lashes turned into visions of Bambi in a brush-fire. But Lumigan’s prescribing information notes that the drug may darken eyelid skin and gradually increase pigmentation of the iris, making even blue eyes browner. Latisse isn’t meant to go directly in or on the eyes, and each Latisse dose uses only 5% of a Lumigan drop. But we all know that whatever you’re wearing on your lashes inevitably goes other places. Whether it be a fully-mascaraed lash that somehow gets stuck in your eye, or flakes of mascara on your face that no one tells you about. So the guidance of a kind and cordial physician may not be so bad after all.